L01EL02 Acalabrutinib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
- L01EL02 Acalabrutinib 2 drugs
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Acalabrutinib 1 drug
- Acalabrutinib (acalabrutinib maleate) 1 drug
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Calquence (Astrazeneca Canada, Capsule) PM | prescription (Rx) |
| Calquence (Astrazeneca Canada, Tablet) PM | prescription (Rx) |
Other classes of the same level
- L01EL03 Zanubrutinib 1 drug
- L01EL05 Pirtobrutinib 1 drug
Other names of the drug class
- English (United Kingdom): L01EL02 acalabrutinib
- German (Austria): L01EL02 Acalabrutinib
- Italian: L01EL02 ACALABRUTINIB
- Turkish: L01EL02 acalabrutinib
- German (Switzerland): L01EL02 Acalabrutinib
- French (Switzerland): L01EL02 Acalabrutinib
- Italian (Switzerland): L01EL02 Acalabrutinib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EL02
Ask your doctor or pharmacist for advice.